Title: Biobanks, data sharing and the risks of privacy breaches: rules and models to control security in the -omics era

Biography:

Elena Salvaterra Robust experience as regulatory project manager in clinical research with a focus on human biobanks. Relevant experience as marketing and sales specialist in biomedical and biotech field. Equipment, services. Good knowledge of IT infrastractures applied to scientific medical and lab fields as well as to chemical, food, manufacturing industries

Abstract

The concept of personalized medicine has brought about a paradigm shift from curing to prevention in medical field. This concept which focuses on preventive medicine has been dramattically improved by the recent development of genome and omics analyses, bioinformatics and biobanks.

According to this prospect, large scale integration of health and genome/omics data is becoming common in today practices and it raises privacy violation risks.

This talk would like to focus on rules (e.g., HIPAA, GDPR, Nih Security best practices for controlled-access data) and methods which relate to potential privacy breaches in order to identify security control measures. In particular it focuses on policies developed to secure patient/donor privacy in relation to data/big data handling in and out of biobanks.